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Abstract
Primary care behavioral health (PCBH) is crucial for providing mental health treatment to
underserved, minority, and uninsured populations. There is a lack of knowledge about accurate
mental health diagnosis at PCBH. Underdetection of mental health symptoms has the potential to
worsen racial and socioeconomic disparities. Using an expert review process, I developed an
abbreviated diagnostic clinical interview (ADCI) for integrated primary care. Next, patients (N =
82) completed the interview after attending PCBH appointments. According to the interview,
63.4% of participants met criteria for a diagnosis, while 64.7% received a diagnosis from their
provider. A large portion of patients met criteria for a somatic symptom disorder (25.8%), likely
associated with data collection occurring during the COVID pandemic. Kappa agreement
between the ADCI and providers’ diagnosis of mood disorders (i.e., depression, anxiety, or both)
was significant but in the fair range. The pattern of disagreement demonstrated that the ADCI
was significantly more likely to detect comorbid depression and anxiety than providers. Overall,
results suggest that the ADCI might be capturing comorbid psychopathology that is
underdetected due to the brief PCBH model. For example, referrals from providers often focus
on more behavioral health concerns, and the brevity of services does not always allow for indepth assessment. The ADCI represents an opportunity to improve mental health service in
primary care by offering a quick mechanism for identifying a more complete picture of a
patient’s mental health concerns.
Keywords: primary care, mental health, diagnostic detection
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Strengthening Mental Health Diagnostic Detection in Integrated Primary Care
Approximately 43.8 million U.S. adults experienced a mental health condition in the past
year (Nguyen & Counts, 2015; Sayers, 2001) with disproportionate rates among those below the
federal poverty guidelines (Americares Mental Health Initiative, 2016; Americares U.S.
Program: Behavioral Health, 2018). Primary care clinics serve as a crucial source of mental
health treatment for underserved, minority, and uninsured populations. The integration of mental
health services within primary health clinics, referred to as primary care behavioral health
(PCBH), leads to improvements in patient functioning and a reduction in mental health
symptoms beyond the care provided by primary care physicians and nurses alone (Bryan et al.,
2012; Sadock et al., 2014). While the PCBH environment has many advantages in health
services provision (e.g., access to a variety of specialties at one clinic, team-based approach,
reduced stigma associated with mental health services), the diagnosis and management of mental
health conditions remains a challenge due to time and resource constraints.
The efficacy of PCBH to provide clinically indicated mental health services for minority
and vulnerable populations is limited by the field’s lack of diagnostic tools (Possemato et al.,
2018). Disparities in health for racial minorities, low socioeconomic status (SES), or underserved
populations are well documented and contribute to disproportionate rates of these individuals
experiencing mental health conditions (D. R. Williams et al., 2010). Though SES often accounts
for much of the observed racial differences in health outcomes, racial differences exist even at
comparable levels of SES (D. R. Williams, 1999). For instance, Black individuals are at greater
risk for not receiving mental health services for depressive symptoms when compared to their
White peers with equivalent symptoms (Alegría et al., 2008). Health disparities and limited
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access to mental health services exist in part due to underdiagnosis of mental health conditions,
resulting in inadequate services and patients experiencing prolonged distress.
PCBH clinics are uniquely designed to provide treatment for racial and SES minorities in
order to address health disparities; however, there is limited research about the diagnosis and
management of mental health conditions for these individuals. Additionally, PCBH lack brief
diagnostic screening tools to determine patients’ mental health diagnoses, contributing to rates of
underdiagnosed minority patients. The objective of this study is to fill in this gap in PCBH
through the development of an abbreviated diagnostic clinical interview (ADCI; Study 1) and
pilot the measure in PCBH clinics to assess feasibility, presence of disorders, and examine the
relationship between patients’ diagnoses provided by their clinician compared to those identified
by the ADCI (Study 2).
Literature Review
The following sections review the current state of the literature on mental health
screening and diagnostic accuracy within the PCBH model to elucidate the needs and potential
benefits of developing an abbreviated diagnostic clinical interview for PCBH.
Integrated Primary Care Behavioral Health
A national movement has focused on integrating mental health or “behavioral health”
services into primary health clinics to provide holistic care. PCBH refers to the inclusive branch
of health psychology and medicine comprised of care of physical health symptoms and chronic
conditions, behavioral medicine conditions (e.g., sleep difficulties, chronic pain, weight
management, and medication adherence), substance abuse, and traditional mental health
concerns (e.g., anxiety, depression, ADHD, and disruptive behaviors; Peek & The National
Integration Academy Council, 2013; Reiter, Dobmeyer, & Hunter, 2018). A systematic review of
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PCBH literature revealed that approximately 25 studies have examined the outcomes of mental
health services at PCBH (Possemato et al., 2018). Overall, integration of mental health services
within primary care leads to improvements in patient functioning and a reduction in mental
health symptoms over the care provided by primary care physicians (Bryan et al., 2012; Sadock
et al., 2014). Moreover, these improvements continue to increase beyond termination of mental
health services, suggesting that patients continue to benefit long-term from brief treatment
(Corso et al., 2012; Sadock et al., 2017).
PCBH involves close collaboration between primary care physicians and mental health
providers to deliver a broad range of health care services to underserved and uninsured
populations, regardless of a patient’s ability to pay (Nguyen, Makam, & Halm, 2016). These
populations are defined by the number of primary care providers per 1,000 individuals, the
number of individuals over 65, infant mortality rate, and the percentage of the population living
in poverty (Bureau of Health Workforce, n.d.; Wong, 2015). In urban settings, these underserved
populations are often minority groups, with a growing number of those communities being Black
(Lanoye et al., 2017; Sadock et al., 2014; Sadock et al., 2017). PCBH has the potential to reduce
the stigma associated with mental health that is often present in these underserved populations
(Ayalon & Alvidrez, 2007; Rao et al., 2007). These findings indicate that PCBH is an effective
modality for providing vulnerable or underserved populations with mental health services
(Possemato et al., 2018).
Additionally, mental health interventions are typically brief, focus on patients’ selfidentified problem areas, and are evidence-informed (e.g., psychoeducation, cognitive behavioral
therapy, motivational interviewing; Hunter, Goodie, Oordt, & Dobmeyer, 2017; Sadock et al.,
2014). These interventions typically focus on anxiety and depression symptoms, along with
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select health problems as needed (e.g., smoking cessation, weight management, insomnia,
chronic pain; Hunter et al., 2017; Sadock et al., 2017). A recent review of PCBH literature
highlighted concerns about the lack of research on treatment fidelity and whether clinical
interventions documented in electronic medical records (EMR) are consistent with patients’
needs and diagnoses (Hunter et al., 2018). Lack of clinical diagnostic procedures could result in
underdetection of patients’ mental health conditions and lack of access to clinically indicated
services. However, traditional clinical diagnostic interviews are not feasible at PCBH due to the
brief model of care.
Within the PCBH model, mental health providers provide care to patients of any age and
any health condition, aim to provide services on the same day as the referral or primary care
appointment, and work closely with other primary care providers to disseminate mental health
knowledge and provide team-based primary care (Reiter et al., 2018). To accomplish these
objectives, clinicians use brief, focused (15-30 minute) appointments to assist with specific
symptoms and patient concerns, or improve functioning (Reiter et al., 2018). This brief treatment
model mirrors the productivity expectations for primary care physicians in the same clinic and
ensures that mental health providers are reaching a large percentage of the clinic population
(Reiter et al., 2018). However, this brief model, along with the low modal number of mental
health appointments, presents logistical challenges to assess adequately for the presence of
mental health diagnoses and provide clinically indicated services.
Due to these limitations, many PCBH instead use symptom screeners such as the
Generalized Anxiety Disorder-7 (GAD-7) or Patient Health Questionnaire-9 (PHQ-9) to alert
providers to potential mental health symptoms and to track changes across appointments (Pollard
et al., 2013). While these screeners document patients’ symptoms, they do not consistently
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measure impairment and distress that might accompany these symptoms which are required to
meet criteria for a mental health disorder. Therefore, these screeners have clinical utility, but
they are not designed to detect all symptoms and are not diagnostic tools for mental health
disorders, nor are they designed for PCBH patients who typically present with a complex,
comorbid array of medical and mental health symptoms (Funderburk et al., 2014; Gask et al.,
2008).
While several structured, empirically-supported diagnostic interviews exist for mental
health conditions, they are used predominately as research tools and rarely implemented in
PCBH for a clinical purpose (Jordanova et al., 2004; Levis et al., 2018). Existing diagnostic tools
are not necessarily applicable to PCBH because (a) they are not tailored for the typical primary
care patient, who is a racial minority, uninsured, attends only one to three mental health
appointments, and often has more than one health condition affecting their lives (Funderburk et
al., 2014; Radcliff, 2017; Sadock et al., 2014) and (b) they are typically utilized in research or
assessment contexts and were not developed for the brevity of PCBH services and solutionfocused appointments (Hunter et al., 2017; Jordanova et al., 2004). For example, the Structured
Clinical Interview for DSM (SCID), Composite International Diagnostic Interview (CIDI), and
the Clinical Interview Schedule-Revised (CIS-R) are diagnostic interview assessment tools that
are consistent with diagnostic criteria; however, administration takes over an hour depending on
the patient’s mental status, and these measures have limited research on their validity in PCBH
(Jordanova et al., 2004). Instead, the development and implementation of a brief structured
diagnostic interview could allow providers to identify mental health conditions and provide
adequate mental health services quickly and accurately.

6
Diagnostic Accuracy
Prevalence rates of mental health conditions in primary care clinics range from 20-50%
of patients seen by medical providers (Ansseau et al., 2004; Kroenke et al., 2007; Spitzer et al.,
1994). Many mental health problems go undetected in primary care settings despite high
prevalence levels and the development of new symptom screeners to assist providers with
assessing patients’ mental health concerns. Borowsky and colleagues (2000) revealed that
physicians were less likely to detect mental health problems for African Americans, men, and
patients less than 35 years of age. However, they were more likely to detect mental health
symptoms in the context of coexisting medical conditions (i.e., diabetes and hypertension) or
patients experiencing more severe mental health diagnoses (i.e., concurrent major depressive
episode and dysthymia). These findings are consistent with literature on the use of decisionmaking heuristics in the medical field. Due to the PCBH model emphasizing brief treatment and
high productivity, providers have limited time with patients, larger caseloads, and potentially
depleted cognitive resources needed to mitigate decision-making errors (Garb, 2005; Graber et
al., 2002). For example, in Borowsky et al.'s study (2000) physicians might have associated
specific medical conditions (e.g., hypertension) with higher rates of mental health problems and
were correct to refer these patients for additional services. However, overreliance on this
heuristic might have also resulted in them overlooking or not screening for mental health
concerns for patients without specific coexisting medical conditions. Overreliance on heuristics
and personal beliefs and attitudes can also result in the development of biases. There is extensive
research about racial biases among providers that contribute to racial health disparities. For
example, van Ryn and Fu (2003) found that doctors perceived Black patients as less intelligent,
less educated, more likely to abuse drugs and alcohol, more likely to fail to comply with medical
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advice, more likely to lack social support, and less likely to participate in cardiac rehabilitation
than white patients, even after accounting for patients’ income, education, and personality
characteristics.
There is limited research about debiasing strategies to help providers improve their
clinical decision-making, despite the plethora of research about providers’ racial biases and rates
of under diagnoses (Croskerry et al., 2013). Structured diagnostic interviews are one form of
debiasing that can help clinicians consider differential diagnoses and identify accurate diagnoses.
Furthermore, accurate diagnosis using a diagnostic interview would assist PCBH providers in
meeting patients’ mental health needs and improve rates of providers collecting all necessary
patient information and avoid relying on biases and assumptions about the typical PCBH patient.
The lack of mental health screening tools tailored to the unique PCBH setting can lead to missed
diagnoses resulting in higher rates of diagnostic adverse events such as receiving inadequate
treatment or inaccurate medication, and prolonging patients’ distress (Piccardi et al., 2018;
Zwaan et al., 2012). Existing diagnostic classification systems, including the Diagnostic and
Statistical Manual of Mental Disorders, 5th edition (DSM-5) and ICD-10, are often difficult to
apply at PCBH due to the brief intervention model, high rates of comorbidity, and problems with
cross-cultural applicability (Gask et al., 2008). However, there are modified diagnostic
classification systems developed for use in PCBH that are amenable for brief administration
protocols and the ADCI development.
The ICD-10 Primary Health Care (PHC) is the most widely used system in PCBH and
provides diagnostic criteria paired with clinical treatment for six disorders/conditions: cognitive
disorders, alcohol/drug use disorders, psychotic disorders, depression, anxiety disorders, and
unexplained somatic complaints that are common in primary care settings (Ustün et al., 1995).
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Disorders were included in the ICD-10 PHC based on their clinical importance in primary care.
Specifically, selected disorders had to meet the following criteria: (a) they are common and able
to be effectively managed in PCBH, (b) medical and mental health providers agree on their
classification and management, (c) they are cross-culturally applicable, and (d) the disorder is
important for public health outcomes (Ustün et al., 1995). These guidelines for the inclusion of
disorders in the ICD-10 PHC are consistent with the PCBH model because physicians are
providing brief, generalized interventions rather than specialty, long-term mental health care that
might benefit from more specific, nuanced diagnoses. Field trials of the ICD-10 PHC were
conducted in more than 50 countries and demonstrated increased detection of some mental health
conditions (e.g., depression and unexplained somatic symptoms) by physicians (Upton et al.,
1999). However, there is not a clear procedure for how the ICD-10 PHC should be implemented
at PCBH. Previous examination of the dissemination of ICD-10 PHC guidelines to providers at
PCBH was not associated with improved detection of mental health disorders (Upton et al.,
1999). Recognizing time constraints, unique challenges, and existing assessments present in the
PCBH setting is key for implementing changes in the diagnostic process. One promising option
is to develop the ICD-10 PHC into an abbreviated diagnostic clinical interview (ADCI) that
capitalizes on structural and organizational elements used to develop other diagnostic interviews
(e.g., SCID) and incorporates symptom screeners already used in PCBH settings.
The ADCI would incorporate the symptom screeners already used in PCBH and follow a
similar development and organizational structure as the SCID. The SCID follows a three-column
format with questions in the left-hand column, corresponding criteria in the middle column, and
the rating and instructions that operationalize the diagnostic criteria in the right-hand column
(Spitzer, Williams, Gibbon, & First, 1992; Williams et al., 1992). The SCID’s grouping by
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diagnosis and inclusion of criteria for each diagnosis allows the clinician to have access to
information about diagnostic features and test hypotheses about differential diagnoses. The SCID
structure also allows for shorter administration times because the interviewer can skip remaining
questions for criteria in a diagnosis after a required criterion is not met for that diagnosis. While
the SCID-5 parallels the diagnostic criteria in the DSM-5, the ADCI will be based on the
diagnoses and criteria in the ICD-10 PHC and relevant sections of the DSM-5 due to diagnostic
updates since the development of the ICD-10 PHC. Replicating the format of the SCID in the
ADCI offers several advantages: (a) it provides the interviewer with necessary knowledge about
the ICD-10 PHC diagnostic criteria; (b) it allows the interviewer to skip remaining questions
after a required criterion is not met resulting in shorter administration times; and (c) the
structured format allows for nurses or other staff members to administer it in advance of a
referral to a psychologist (Spitzer et al., 1992; Williams et al., 1992). Due to the prevalence of
mental health concerns and the harm associated with lack of diagnosis, it is vital to develop a
mechanism to provide quality diagnoses. Development of an empirically-supported ADCI could
allow PCBH providers to quickly and accurately identify patient diagnoses and insure clinically
indicated services are provided (Basco et al., 2000).
Lacking clinical diagnostic tools has potentially lasting effects in the PCBH environment,
particularly for populations who already have increased difficulty accessing treatment (Graber,
2013; Makary & Daniel, 2016; Sayers, 2001; Zwaan et al., 2012). Missed diagnosis of mental
health conditions for these individuals could result in increased diagnostic-associated adverse
events such as receiving inadequate treatment, inaccurate medication, and prolonging patients’
distress (Graber, 2013; Makary & Daniel, 2016; Sayers, 2001; Zwaan et al., 2010). In
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comparison to other types of medical errors, diagnostic errors are associated with more severe
and prolonged harm to patients (Sevdalis et al., 2010; Zwaan et al., 2010).
The Present Study
An important step towards improving PCBH includes the development of a diagnostic
tool applicable to the clinical setting and patients. The development of a diagnostic tool and the
review of service provision will help assess rates of underdiagnosis and treatment. First, this
project will provide important information about how to feasibly assess for mental health
diagnoses for PCBH patients through the development of the ADCI. A feasible diagnostic
clinical interview for PCBH would expand knowledge about the prevalence rate of mental health
disorders present at PCBH, inform PCBH about the mental health services that should be
provided to their patients, and improve patient quality of care. Dissemination and
implementation of the ADCI could help to reduce rates of underdetection of mental health
symptoms that might contribute to racial health disparities. Second, this study aims to pilot the
ADCI in PCBH to assess its feasibility and the presence of mental health concerns at local PCBH
clinics. Additionally, findings for the ADCI will be compared to diagnoses from clinicians to
help understand how the ADCI could benefit PCBH, clinicians, and patients. For example,
increased knowledge about prevalence of disorder could help reduce health disparities as a result
of underdetection of symptoms, minimize potential harm to patients, and increase the efficacy of
services provided.
In sum, assessment and provision of mental health services could be improved through
the development of a clinically appropriate ADCI (Study 1) and the use of this novel ADCI to
assess of mental health concerns at PCBH and compare findings to clinicians’ provisional
diagnoses (Study 2).
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Study 1
The aim of the first study is to develop the abbreviated structured diagnostic clinical
interview (ADCI) protocol appropriate for the context of PCBH. The ADCI will be developed
from the ICD-10 PHC and DSM guidelines using a method similar to the development of the
SCID (Spitzer et al., 1992; Williams et al., 1992). The ADCI will undergo expert and iterative
review using the Delphi method and snowball sampling to identify expert reviewers, starting
with clinicians and supervisors at PCBH located in Richmond, VA and psychopathology experts.
Development will conclude when expert agreement reaches at least 80% with no revisions
requested.
Study 2
The aim of the second study is to pilot the ADCI (Study 1) with PCBH clinicians, assess
the feasibility of the measure, collect information about disorders prevalent at these clinics and
compare results from the ADCI to provisional diagnoses provided by PCBH clinicians. The
administration of the ADCI and review of provisional diagnoses will occur at PCBH clinics,
specifically the Ambulatory Care Clinic (ACC) and Hayes E. Willis Clinic (Hayes).
Approximately 200 adult primary care patients who have attended at least one mental health
appointment in the past two weeks were contacted via phone to complete the ADCI. Next,
participants’ clinicians were contacted to provide provisional diagnoses. Last, concordance
calculations identified the rate of agreement between the ADCI-identified mental health
diagnoses and participants’ provisional diagnoses.
The outcomes of the study will generate a new clinical diagnostic tool that mental health
providers will be able to implement in PCBH. Additionally, the study will help clinical settings
gain a better understanding of their patients’ needs and improve knowledge about the mental
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health disorders present in these communities. These findings have implications for PCBH to
improve mental health diagnostic procedures and address health disparities. The concordance
rates between ADCI and clinicians’ diagnostic methods is an exploratory aim to determine
whether the ADCI is appropriately capturing patients concerns. No specific agreement was
expected between ADCI and clinicians’ reported diagnoses due to the brevity of the PCBH
model and behavioral health appointment along with the focus of addressing referrals and
patients’ concerns rather than assessment and diagnosis.
Method
Study 1 involved the iterative development of the ADCI using expert feedback. Study 2
comprised a one-time prospective administration of the ADCI via telephone to local PCBH
patients paired with collection of provisional diagnoses from these patients’ clinicians. Last, the
concordance rate was calculated to examine efficacy of the ADCI and/or unmet needs of the
patient population.
Study 1
The ADCI was developed to parallel the diagnostic criteria from the ICD-10 PHC and
DSM. The feasibility and applicability of the diagnostic interview was first assessed using the
Delphi method to solicit feedback from experts in psychopathology, along with clinical
supervisors and mental health providers at local PCBH clinics. These experts are not considered
study participants, as no data about them was analyzed; instead, they are considered
collaborators who shared their expertise.
Expert Reviewers. A total of 14 reviewers were recruited, consistent with past research
using the Delphi method (Christmann, 2009; Kraj, 2015). Reviewers were recruited using
snowball sampling, starting with Drs. Keeley, Perrin, and Rybarczyk. The team of expert
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reviewers was recruited via email and was comprised of four experts in psychopathology along
with five clinical supervisors and five mental health providers from local PCBH clinics.
Procedure. An initial bank of diagnostic questions was developed from symptom
screeners typically used in PCBH (e.g., PHQ-9, GAD-7, AUDIT) and from the diagnostic
guidelines in the ICD-10 PHC. Questions were separated into two types: (a) initial screener
questions about symptoms required to qualify for a mental health disorder and (b) diagnostic
questions to identify the specific mental health disorder. The development and format of these
questions paralleled the procedure from the development of the SCID (Segal et al., 1994; Spitzer
et al., 1992; Williams et al., 1992). Questions were grouped by diagnosis and by criteria in a
three-column format with questions in the left-hand column, corresponding diagnostic guidelines
in the middle column, and the symptom rating in the right-hand column. Once all potential
questions were collected or written, they underwent a revision or exclusion process to eliminate
redundancies, vague wording, or improve over-specificity and sensitivity. After a final list was
developed, branching logic was drafted. For example, if a required guideline was not met for a
specific disorder, the remaining questions for that diagnosis were skipped. This branching logic
was essential to ensure shorter administration times and to reduce burden on providers and
patients. Last, an electronic version was developed in Qualtrics, a HIPAA compliant survey tool,
for easier administration, presentation of diagnostic results, and data collection.
All expert reviews were completed via email and brief Qualtrics survey. First, experts in
psychopathology and PCBH were asked to provide general feedback about the plan for
development, feedback, and revision. The reviewers also had the opportunity to provide general
feedback about the initial items, questions, and structure.
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Following integration of initial feedback, reviewers received prompts to provide specific
feedback about a variety of aspects of the ADCI; for example, final items, structure, and the
feasibility and applicability of the ADCI for PCBH. Experts used a feedback survey in Qualtrics
to provide an overall rating of the ADCI, along with ratings and comments about the following
domains: previous revisions made, user experience, and applicability to PCBH on a seven-point
Likert scale (1 being “not appropriate” to 7 being “extremely appropriate”). The feedback survey
also prompted experts to provide additional explanation or rationale if they provided low ratings
on any of the above domains. On the first round of the feedback survey, reviewers reached over
an 80% agreement on all ratings of the ADCI; thereby the review process was completed over a
total of three phases.
Study 2
The second study compared diagnostic results from the ADCI (Study 1) with provisional
diagnoses provided by the participants’ clinicians. The ADCI was administered to eligible
patients who consented to participate in the study via telephone after attending a mental health
appointment at a PCBH clinic. Next, their clinician was contacted to collect a provisional
diagnosis that informed treatment and intervention. Last, concordance ratings were calculated for
the agreement between the ADCI-assessed diagnoses and clinicians’ provisional diagnoses.
Selected PCBH Clinics. The two PCBH selected for the study are located in Richmond,
VA and are associated with Virginia Commonwealth University (VCU). The Ambulatory Care
Clinic (ACC) and Hayes E. Willis Clinic (Hayes) provide services to underserved and minority
groups with an overrepresentation of racial/ethnicity minorities (Radcliff, 2017; Sadock et al.,
2014, 2017).
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Participants. Literature states that to detect a fair to moderate kappa rating (κ = 0.400.50) at 90% power and .05 alpha, a sample of at least 66 participants is needed (Bujang &
Baharum, 2017; Sim & Wright, 2005). Thus, a final sample of 82 ensured that the study was
adequately powered to detect agreement while also remaining feasible based on patient flow in
clinics and comparable to similar studies conducted at these PCBH (Radcliff, 2017; Sadock et
al., 2014, 2017). Anticipating that approximately half of patients would decline to participate, I
planned to contact at least 200 potential participants. Patients were screened using their EMR to
ensure they met inclusion criteria. To be included, participants had to: a) be 18 years or older, b)
speak English as their primary language, c) attend at least one mental health appointment in the
past two weeks, and d) have a telephone number on record and access to an email address to
receive electronic gift cards. Participants were excluded if they were under the age of 18, their
primary language was something other than English, or they did not have both a telephone
number and access to an email account.
Procedure. Five research assistants (RAs) were trained to administer the ADCI via
telephone. Each RA was required to complete a minimum of 8 hours of training before they were
cleared to complete the ADCI independently. Training consisted of a four-hour class, two
practice interviews with peers, and required to pass two test interviews that were supervised by
myself or Dr. Keeley. See Table 1 for interrater reliability for each RA’s practice interviews;
reliability was significant and in the acceptable range for all interviewers for both practice
interviews.
Table 1
Interrater Reliability

Interviewer 1
Interviewer 2

Practice Interview 1
κ
95% CI
p
.639
.494, .761
.001
.706
.570, .838
.001

Practice Interview 2
κ
95% CI
p
.768
.624, .895
.001
.829
.695, .945
.001
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Interviewer 3
Interviewer 4
Interviewer 5

.745
.828
.891

.607, .881
.697, .929
.786, .966

.001
.001
.001

.793
.745
.903

.695, .886
.607, .881
.802, .976

.001
.001
.001

Over the course of data collection from April to November 2020, patients who attended
behavioral health appointments at either ACC or Hayes received flyers notifying them about the
ongoing study and providing instructions for how to opt out of participation. Next, eligible
patients received an initial phone call inquiring whether they would be interested in participating
in the study. If interested, they received a brief description of the study, information about
compensation, then completed the consent procedure. Consent was obtained verbally before any
conducting study-related procedures. All participants were offered an emailed copy of the
informed consent containing contact information for the study personnel and for the VCU Office
of Research Subjects Protection. Additionally, patients who were not available to participate at
the time of the initial phone call were provided the option to schedule a time that worked with
their schedule. HIPAA compliant voicemails were left for patients who did not answer,
containing information about whom to contact if interested in participating in a VCU research
study. Participants’ return calls were saved in a password protected voicemail box in a secure lab
space. Participants who did not answer or return voicemails after two attempts over the course of
two weeks were excluded from the study.
Interviews averaged approximately 28 minutes (ranging from approximately 7 to 120
minutes) depending on rapport, participant participation, and mental health history. See
Appendix A for a script of the telephone interview. During the diagnostic phone interview,
interviewers coded patients’ answers into the ADCI survey on Qualtrics. Individuals who
completed the interview received a $10 electronic Amazon gift card to their email address. If
participants reported suicidal ideation or self-harm, interviewers encouraged participants to share
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this information at their next PCBH appointment and offered them a list of mental health
resources available to them in the community. Additionally, if a participant reported suicidal
ideation, the interviewer was required to contact Dr. Keeley, PhD, LCP, for risk assessment and
determine the need for emergency interventions (e.g., safety planning or hospitalization).
Throughout the study, only I had access to participants’ EMR records to protect private
health information. After the diagnostic interviews, I reviewed participants’ EMR for descriptive
information (i.e., date of birth, race, gender) and name of the participants’ clinicians. Next, these
clinicians were contacted through REDCap, a HIPAA compliant survey site, to provide
provisional diagnoses for each of their patients that participated in the study. Surveys pre-filled
with patient information and a check list of diagnoses were sent to the clinician; the surveys were
protected.
Statistical Analysis Plan
First, I provide a detailed overview of the ADCI development and revision process.
Patient demographics were compared across PCBH clinics using independent t-tests. Next, I
provide a summary of diagnostic results from both the ADCI and clinicians and use independent
t-tests and chi-square analyses to compare across diagnostic methods. Last, I assessed the
agreement between each of the participants’ diagnoses from the ADCI and from their clinicians.
Concordance ratings were measured using kappa (κ), a statistical measure of percent agreement
that takes into account the possibility of agreement occurring by chance (Bujang & Baharum,
2017). I calculated an overall kappa concordance of diagnosis along with separate kappa
analyses for each diagnosis to examine potential differences in concordance by diagnoses. I also
calculated bootstrapped 95% confidence intervals to measure the statistical reliability of the
degree of agreement.
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Results
Study 1
Item development was inspired by symptom screening measures (e.g., PHQ-9, GAD-7,
AUDIT, and primary care behavioral health screeners) and diagnostic interviews (e.g., SCID).
Initial item development created approximately 200 questions that were sent to reviewers. The
first round of feedback was focused on revising item phrasing and organization along with
whether and/or how to best include the following elements: diagnostic criteria, screening
questions, a brief mental status exam, and a brief cognitive exam. Several of these concerns were
addressed by finalizing the interview’s structure and organization; for specific feedback and
revision by sections see Table 2. See Figure 1 for an example of the three-column format and
initial branching logic.

Figure 1. Example of three-column format and branching logic from the screening section.
Table 2.
First Round of Feedback and Revisions
Aspect of ADCI
Feedback
Questions Overall
Some questions contained too
much overlap across diagnoses,

Revisions
Increased specificity of
questions to reduce overlap, used
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too much psychological jargon,
adjust frequency of how often
patients experience symptoms to
meet criteria
Diagnostic criteria

Too lengthy, too in depth
regarding differential diagnoses
and patient vs. family
presentation

Screening Questions

Too many questions and too
much overlap of symptoms
across questions, both of which
would result in completion of
more modules and be
burdensome on patients and
interviewers
Explore ways to abbreviate and
distinguish which questions are
completed by the interviewer
and which are questions posed to
the patient, and should these
questions occur at the end or
beginning of the interview
Cognitive impairment is a
transdiagnostic symptom and
expert reviewers felt a brief
cognitive screen would help
differentiate cognitive and mood
disorders

Brief Mental Status
Exam (e.g., mood,
behavior, thought
process)

Brief Cognitive Exam

more colloquial language for
mood and substance use, revised
phrasing to increase frequency of
symptoms so question met
threshold for diagnosis
Diagnostic criteria were
abbreviated to fit in the middle
column and included only the
diagnostic symptoms relevant to
each question
Differential diagnosis was
incorporated into the coding of
branching logic
Reduced number of questions by
removing questions about
transdiagnostic symptoms

Abbreviated number of
questions, questions to be
answered by the interviewer
moved to the end to reduce
burden on patients

Included questions for both
patient’s subjective selfassessment and brief cognitive
exam using validated questions.
Additionally, screened for
medical etiology of cognitive
symptoms

After the initial round of edits was made and three column structure and branching logic
were implemented, the interview was sent back out to reviewers. Reviewers provided feedback
using a combination of comments, tracked changes, and written summary via email. The format
of feedback was flexible to accommodate individual differences in preferred method of
collaborative writing. This round of feedback was focused significantly more on larger themes of
the ADCI. For example, most reviewers provided general feedback about each diagnostic
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module (e.g., depression, anxiety, cognition) and formatting. The two major pieces of feedback
were (a) numerous questions and concerns about scoring, interpretation, and measurement
validity of the cognitive module and (b) that the organization of screening questions, modules,
and results summary should be more intentional to create a consistent procedure that also makes
clinical sense. To address this feedback, the cognitive module was removed, and the order of
screening questions and modules was revised to mirror base rate presentation of mental health
disorders in PCBH. For a more detailed explanation of revisions, see Table 3.

Table 3.
Second Round of Feedback and Revisions
Aspect of ADCI
Feedback
Length and
Length and complexity of
Organization
organization and instructions
would be burdensome to
interviewer, thereby impacting
feasibility in PCBH settings

Cognitive Module

Consulted expert reviewers for
threshold of accuracy to score
brief cognitive assessment.
However, reviewers had
numerous suggestions and
requests for assessment and
validation that were beyond the
aims and scope of the study, and
not feasible in PCBH.

Scoring convention

Yes and No are limited scoring
options, so reviewers
recommended adding third
option and operationalizing.

Substance Use
Disorders

Discouraged grouping
substances by “alcohol, tobacco,
and other drugs.” Reviewers

Revisions
Eliminated questions that the
majority of reviewers found
unnecessary or redundant. Order
of screening questions and
modules was revised to be
consistent with base rate of
presentation in PCBH.
Eliminated module due to low
base rate in primary care unless
working with older adults. Also,
there are several brief, validated
cognitive screeners already in
existence. Instead included a set
of brief screening questions
located at the end of the
interview and recommendations
for brief screening tools (e.g.,
MOCA, MMSE)
“Unknown” or “?” was the
original third option, revised to
“unable to assess” so that
patients or interviewers are able
to document a lack of
information or limited
assessment
Created a two-tiered set of
questions to assess substance
use. Questions first assessed
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suggested making module more
streamlined and structured to
precisely assess quantity and
frequency of use
Psychosis

Results Summary

Screening question for delusions
lacks specificity and picks up on
OCD or trauma responses.
Request to include a caveat for
cultural beliefs in the diagnostic
criteria
Reviewers recommended
outlines at end of interview to
help reduce interviewers’
cognitive burden. Suggested
elements: results of risk
assessment, recommended next
steps in care/referrals for
cognitive evaluation, substance
use treatment, and safety
planning

frequency and quantity of
substance use then assessing
diagnostic criteria (e.g.,
symptoms of tolerance,
withdrawal, and cravings).
Rephrased screening question
for delusions. In the middle
column, added caveat for cultural
beliefs.

Summary page lists: modules
completed, mental status exam,
provisional diagnoses, review of
risk assessment, and referral
suggestions

Between round two and three of reviews, the ADCI was uploaded into Qualtrics.
Although Qualtrics has many advantages, such as being HIPAA compliant, and offering complex
branching logic and survey distribution options, it was not able to accommodate the proposed
three column format. Several alternative formats were trialed. The best option that clearly
presented all information was a two-column format, with questions remaining in the left-hand
column and scoring in the right-hand column, but with extra space over the scoring for
diagnostic criteria and instructions; see Figure 2 for an example and link to the ADCI can be
found in Appendix A. During this next round of feedback, reviewers were asked to use a
feedback survey, also in Qualtrics, to collect their comments, suggestions and quantitative
ratings of the ADCI. Ratings were collected on the domains of previous revisions completed,
user experience, and applicability to PCBH on a seven-point Likert-type scale (1 being “strongly
disagree” to 7 being “strongly agree”). We required at least 80% of expert ratings to be greater
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than or equal to a rating of 5 “somewhat agree” to find the domain acceptable. Ratings for all
three domains met this benchmark. User experience received an average rating of 5.28 (SD =
1.08), and no reviewers rated it below a 5 or “somewhat agree.” The removal of the cognitive
module received an average rating of 5.60 (SD = 1.57). One reviewer rated the removal of the
cognitive module as “disagree” (2 out of 7) and their feedback was used to improve the results
summary page with recommendations for cognitive assessment. The feasibility of using the
ADCI was rated on average as 5.64 (SD = 1.36); one reviewer provided a rating of “disagree” (2
out of 7). Based on their feedback, the study methodology and the ADCI were revised to clarify
the target population and help discriminate the measure as diagnostic in contrast to existing
measures which are screening tools. The majority of these revisions occurred during the
development of the complex algorithm that takes into account comorbid symptoms and
differential diagnosis. The ADCI’s diagnostic algorithm is a key factor that separates it from
existing symptom screening tools like the GAD-7 or PHQ-9. See Table 4 for a more detailed
explanation of revisions and qualitative data of reviewers’ ratings.
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Figure 2. Example of final layout from the screening section.
Table 4.
Final Round of Feedback and Revisions
Aspect of ADCI
Feedback
Depression
Confident that module will review
necessary symptoms of depression
for diagnosis.
Question on why use “one month”
vs “two weeks” cutoff of symptom
presentation.
Question about amount of weight
change that is diagnostically
significant
Anxiety
Confident that module will assess
symptoms for a variety of anxiety
diagnoses.
Add other situations that could elicit
social anxiety.
Spacing issue, questions and
responses are not aligned.
Substance Use
Good reception for changing first
Disorders
page of module to collect frequency
and quantity of use.
Concerns that withdrawal symptoms
differ across drugs.

Revisions
Question stem was changed from
“in the past month” to “in the past
two weeks” to match diagnostic
criteria in DSM-5
There is not clear consensus for how
to operationalize “significant weight
change;” therefore, whether a
patient met this criterion was left up
to patient’s subjective opinion
Added social situations with friends
and work that might lead to anxiety.
Revised formatting to resolve
misalignment between question and
responses

List of withdrawal symptoms was
expanded to include wider variety
of symptoms; however, unable to
reduce list due to individual
differences in presentation of
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Concerns about tobacco: smoking
vs. nonsmoking, withdrawal
symptoms, how to score a range of
number of cigarettes.

Somatic
Symptom
Disorder

Psychosis

Suicide Risk
Assessment
Mental Status
Exam

User Experience

Removal of
Cognitive
Module

Specific item-level edits to response
options and administration
instructions.
Clarify whether patients’ medical
conditions and concerns are
diagnostic criteria and include a
space to record patients’ response.
Include specific phrasing for how to
assess spirituality or religiosity.
Resolve minor errors in formatting
and recording description of
patients’ psychoses.
Recommend moving the psychosis
module earlier if patient endorses
symptoms during screening.

Error in branching logic on the
results summary page; feedback on
summary page is simplistic
Separate questions for patients to
answer from those for the
interviewer to answer to avoid
administration errors
Maybe add a “back” button so
interviewer could change options
and/or in case a patient changes
their response.
Add space to expand upon “unable
to assess,” also applies to reset of
interview
Requested inclusion of validated
measures of cognitive functioning

withdrawal. Created separate
questions for smoke vs. smokeless
tobacco during screening. Added
more information about cut-off
ranges for alcohol and number of
cigarettes for nicotine dependence
during screening questions
Copy-editing of items to make
scoring clearer and provide spaces
for interviewer to record patients’
medical conditions and symptoms

Included instructions on how to
probe for whether symptom is a
cultural belief to a normative
degree. Fixed formatting to make it
clearer how to score questions.
Psychosis screening questions are
the last questions, and if patient
endorses either symptom, the
psychosis module will be completed
next for better flow and interview
rapport.
Revised branching logic and
collected practice interviews to
ensure survey flowed properly
Questions that need answers from
patient were moved earlier and
script ends interview with patient
before proceeding to questions
meant for interviewer to answer
Back button was added but
occasionally, unable to go back due
to branching logic
Added a free-text box at the end of
each page to collect notes, notes are
then summarized on the results page
at end of interview
If patient screens positive for
cognitive difficulties, a few
validated measures of cognitive
functioning are included in the
recommendations in the results
summary at the end of interview
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Feasibility in
PCBH setting

Requested additional information
about how the ADCI would be used
in PCBH, how it differed from
screening measures and the
rationale for the inclusion of select
disorders

Brief summary of study rationale
was provided to the reviewers at
beginning of the study. Key
rationales are a) any provider could
use measure to assess whether
patients would benefit from mental
health services, b) existing
screening measures are not designed
to be diagnostic tools and c)
included disorders were limited to
those with highest rate of
prevalence in primary care

Study 2
Participants. Between April and November 2020, 223 patients met eligibility criteria
and were contacted. Approximately 31.80% of patients declined (n = 71) to participate and
31.4% did not return calls or voicemails within the two-week window (n = 70). To improve
patient engagement, our research team spent a significant amount of time calling patients. RAs
spent a total of 8-10 hours per week over 30 weeks calling patients; several patients expressed
interest in participating, resulting in approximately 470 calls back and forth between RAs and
patients. The final sample contained 82 patients, see Table 5 for demographic information by
primary care clinic. Across the two clinics, participants’ race (2(3) = 0.37, p = 0.83), sex (2(1)
= 1.02, p = 0.31), and age (t(80) = 0.41, p = 0.68) did not differ significantly.
Table 5.
Participant Demographics
Ambulatory Care
Clinic
n
%
Sex (%)
Female
Male
Race (%)
African
American/Black
Caucasian

Hayes E. Willis
Clinic
n
%

n

%

Total

40
12

76.9
23.1

20
10

66.7
33.3

60
20

73.2
26.8

35

67.3

19

63.3

54

65.9

15

28.8

9

30.0

24

29.3

26
Other
Age M (SD)
Total (N)

2
3.8
49.64 (12.68)
52
100

2
6.7
48.29 (16.42)
30
100

4
4.9
49.15 (14.08)
82
100

Feasibility. Time between patients’ behavioral health appointments and completion of
the ADCI averaged 11.85 days (SD = 7.85, ranging 1-41 days). Participating in the study took
participants an average of 42.32 minutes (SD = 26.65); a portion of that time was spent on
consent and study protocol, which averaged 15.07 minutes (SD = 7.85). Excluding study
protocol, the ADCI took an average of 27.89 minutes (SD = 17.20, ranging 6.45-126.02
minutes). Per our RAs, receiving training to administer the ADCI improved feasibility, data
collection, and their confidence for scoring participants’ responses. A brief, one-session training
conducted for a total of 3 hours was sufficient for our interviewers. However, this time could
likely be shortened to approximately an hour for providers with more clinical experience
(medical assistants, nurses, etc.). At the beginning of the study, patients were informed that the
interview varied from 30-60 minutes. Occasionally, patients expressed concerns that an hour
would be too long. Patients were reassured to know that we were tracking the average
completion time which was constant at ~30 minutes. Only one patient was unable to complete
the interview due to time constraints. There were no reported technical issues (e.g., wrong
questions, wrong modules). If interviewers wanted to revise scoring after completing an
interview, Qualtrics made it very easy to edit select questions. The majority of problems
occurred due to remote data collection, collecting data during the COVID pandemic, and
conducting interviews using remote access to a landline. For example, consultation with the
supervising licensed psychologist involved placing participants on hold and then making a
second call to Dr. Keeley. Occasionally, it required more than one attempt to connect the second
call. No calls with participants were dropped during calls for supervision. However, several RAs
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and patients did have connectivity issues due to reduced internet and cellular data bandwidth at
the beginning of the pandemic. This resulted in poor sound quality but did not interfere with
completing interviews. Conducting the study remotely was an added challenge for recruiting
participants. Some patients were initially interested but declined to participate after learning
more about the study and completing the consent procedure. One patient placed a formal
complaint with the study PI and clinic due to not receiving an opt-out study flyer and felt their
privacy was violated. The situation was resolved effectively with apologies from the study’s
research coordinator, the clinic supervisor, and the patient’s clinician.
Mental Status Exam. Data on participants’ current mental status was collected in two
ways: a subjective report from the participant and interviewer’s perception of the participant.
Most patients shared having depressed mood (29.3%, n = 24), followed by appropriate and full
range of mood (24.4%, n = 20), angry or irritable mood (18.4%, n = 15), anxious mood (13.4%,
n = 11), other (10.9%, n = 9), and unable to assess mood (3.6%, n = 3). Very few patients
endorsed a period of manic mood that lasted more than a few days (14.6%, n = 12). From the
interviewers’ perspectives, most patients presented as having appropriate or full range of affect
(48.8%, n = 40), followed by flat affect (28.0%, n = 23), constricted or blunted (19.5%, n = 16),
and labile affect (3.7%, n = 3). However, interviewers’ assessment of mood was limited due to
the ADCI occurring via telephone.
Participants’ attention and memory were assessed through self-report and from the
interviewers’ perspective. The majority of patients (80.5%, n = 66) reported concerns about their
cognitive functioning and would have benefitted from their primary care doctor completing a
MoCA or MMSE. Of the 66 patients who would benefit from cognitive screening, 78.8% (n =
52) reported concerns about inattention and difficulty concentrating, 43.9% (n = 36) reported
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memory difficulties, and interviewers reported that 29.3% (n =24) exhibited inattention or
memory difficulties that interfered with the interview process.
Interviewers also assessed participants’ thought process, content, and speech. The
majority of patients had appropriate and logical thought processes (79.3%, n = 65), a few were
circumstantial in their answering of questions (17.1%, n = 14) followed by tangential thought
processes (2.4%, n = 2). Out of the 18 participants who screened positive for psychosis, seven
endorsed auditory hallucinations, six endorsed visual hallucinations, and six shared delusional
thinking. Patients’ speech was most often characterized as normal (52.4%, n = 43), and volume
was often described as soft (41.5%, n = 34) and occasionally loud (7.3%, n = 6). Rhythm of
speech was often described as slow (42.7%, n =34) and rarely pressured (3.7%, n = 3).
ADCI Diagnostic Process. Participants completed a set of screening questions to
determine which diagnostic modules should be completed. A surprising number of patients
screened positive to complete the psychosis module: 22% (n = 18). Of those participants, only 6
or 33.3% met criteria for a psychotic diagnosis. The majority of patients (90.2%, n = 74)
screened positive for depression; however, only 43.2% (n = 32) of those patients met criteria. A
significant number of participants also screened positive for anxiety (86.6%, n = 71). Thirtyeight percent of those patients (n = 27) met criteria for generalized anxiety disorder, while 26.8%
(n = 19) met criteria for panic disorder. An unexpected number of patients screened positive for
somatic concerns (68.3%, n = 56) and 55.4% of those patients (n = 31) met criteria for somatic
symptom disorder. Last, 39% of participants (n = 32) expressed concern regarding their
substance use or a high quantity of substance use; however, only one patient met criteria for a
substance use disorder. To meet criteria for the above disorders, the patient had to endorse
functional impairment in one or more domains for functioning; see Table 6 for frequencies.
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Participants most often reported that mental health symptoms made it difficult to maintain home
responsibilities and relationships with friends and family.
Table 6.
Frequency of Functional Impairment by Domain
Yes
No
n
%
n
Work
28
34.1
41
Friends/Family
36
43.9
43
Home
43
52.4
38
Self
22
26.8
59
Other
32
39.0
49

%
50.0
52.4
46.3
72.0
59.8

Unable to Assess
n
%
12
14.6
0
0
0
0
0
0
0
0

The anxiety and depression modules contained additional questions for instances when
participants triggered one of these modules after completing another (e.g., substance use) but did
not endorse the original screening questions. Seven participants triggered these discrepancy
check questions for the depression module. Only one met criterion for a diagnosis of depression,
five reported subclinical depressive symptoms, and one declined to answer depression questions
due to feelings of sadness and hopelessness being more related to marijuana use than depression.
Five people triggered the discrepancy check questions in the anxiety module. None met criteria
for generalized anxiety or panic disorders. However, three reported subclinical social anxiety and
the other two were experiencing subclinical anxious mood and difficulty controlling worry.
Suicidality. The suicide assessment module was completed for 12.2% of participants (n
= 10). Of those 10 patients, one declined to answer questions about suicidality, and four endorsed
passive thoughts only. One patient shared passive thoughts and plan, but no intent. Three
reported active thoughts of suicide without plan or intent. One patient shared active thoughts of
suicide with intent, but no plan and one patient shared active thoughts with plan and intent. None
reported suicidal and/or preparatory behaviors. Each participant who met criteria for a suicide
risk assessment triggered study protocol for the interviewer to consult their clinical supervisor,
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Dr. Jared Keeley, to discuss risk and resources. All patients reported either discussing these
thoughts with their PCBH clinician and/or having a follow-up appointment with their clinician
scheduled. There were an additional five participants who shared a history of suicidal ideation
but denied any ideation currently or in the past month.
Comparing Diagnoses from ADCI and Clinicians. After participants completed the
interview, their clinicians were contacted to provide diagnoses. See Table 7 for the frequency of
diagnoses from both the ADCI and clinicians. Chi-square analyses were used to examine
differences between clinicians’ and ADCI diagnoses. Across the two diagnostic methods, rates of
depression (2(1) = 1.16, p = 0.23), generalized anxiety (2(1) = 0.78, p = 0.38), substance use
disorders (2(1) = 0.08, p = 0.78), and somatic symptom disorder (2 1) = 3.37, p = .06) did not
differ significantly. Clinicians and the ADCI differed significantly on diagnosis of panic disorder
(2(1) = 4.50, p = 0.03) and on the number of disorders for which participants met criteria (2(2)
= 10.93, p = 0.03).
Table 7.
Frequency of Diagnoses by ADCI and Clinicians
ADCI
Clinicians’ Diagnosis
n
%
n
%
Depression
32
26.7
30
37.9
GAD
27
22.5
28
35.4
Panic*
18
15.0
5
6.4
Substance Use Disorders
1
0.83
6
7.6
Somatic Symptom
31
25.8
2
2.5
Disorder
Psychosis
6
5.00
0
0
Other (self-reported)
5
4.17
8
10.2
Total
120
100
79
100
Does not meet criteria
30
36.6
29
35.3
One disorder*
17
20.7
39
47.6
>1 disorder*
35
42.7
14
17.1
Note. * denotes significant difference between diagnoses for the ADCI and clinicians
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Next, kappa analyses were used to examine the concordance between patients’ diagnoses
from the ADCI and diagnoses provided by their mental health provider. See Table 8 for
statistical results of kappa analyses. First, diagnoses were dichotomized into whether or not
participants met criteria for a disorder; the ADCI and clinicians did not show significant
agreement on whether participants did or did not meet criteria for any diagnosis.
Table 8.
Kappa Concordance (ADCI vs. Clinicians)
κ
95% CI
p
Met Criteria for a Disorder
-.030
-.241, .212
.787
Mood Disordersa
.140
.003, .277
.025
Met Criteria for an Anxiety Disorderb
.223
-.022, .445
.044
Depression
.119
-.098, .348
.281
Generalized Anxiety Disorder
.097
-.118, .329
.378
Panic Disorder
.183
-.044, 420
.034
Substance Use Disorders
-.021
-.054, .000
.777
Somatic Symptom Disorder
.079
.000, .193
.066
Number of Disorders
.076
-.068, .213
.269
(None, one, >1)
Note. aPatients were grouped as either meeting criteria for no disorder, depression, an anxiety
disorder or both depression and anxiety.
b
Patients were grouped as meeting criteria for an anxiety disorder (either Generalized Anxiety or
Panic) or not meeting criteria for an anxiety disorder

Participants were then categorized as meeting criteria for depression, anxiety, or both,
which was significant but in the fair range. The ADIC and clinicians demonstrated more
agreement for participants who did not meet criteria for a disorder rather than depression,
anxiety, and both. The pattern of disagreement demonstrated that the ADCI was significantly
more likely to detect comorbid depression and anxiety than providers. See Table 9 for frequency
of mood disorder diagnoses across both diagnostic modalities.

A
D
C
I

Table 9.
Frequency for Diagnosis of a Mood Disorder

No diagnosis

No Diagnosis
20

Diagnosis from Clinicians
Depression
Anxiety
Both
9
8
4

Total
41

32
Depression
Anxiety
Both
Total

5
2
6
33

2
3
5
19

2
4
5
19

0
0
7
11

9
9
23
82

Next, kappa was calculated for one disorder at a time. Agreement on the presence of an
anxiety disorder was significant and in the fair range, see Table 10 for frequency of patients
meeting criteria for anxiety disorder. The ADCI and clinicians seemed to identify similar
numbers of patients with and without a disorder. The confidence interval for this kappa does
contain zero. Kappa includes a measure of variability and when it is calculated it depends on
sample size. Therefore, the inclusion of zero in the confidence interval is likely a reflection of
small sample size rather than nonsignificant results (Bujang & Baharum, 2017; Sim & Wright,
2005). Agreement for panic disorder was also significant and in the fair range; the ADCI was
more likely to detect patients meeting criteria for panic disorder than providers. See Table 11 for
frequency of panic disorder diagnoses across modalities. There was no significant agreement
between the ADCI and clinicians for depression, generalized anxiety disorder, substance use
disorder, or somatic disorder. The ADCI and clinicians also did not significantly agree on the
number of disorders for which participants met criteria; the ADCI identified significantly higher
rates of comorbidity. Kappa could not be calculated for psychotic disorders due to no clinicians
reporting patients with psychosis. See Appendix B (Tables 12-18) for frequency counts for
nonsignificant kappa analyses.

ADCI

Table 10.
Frequency for Diagnosis of an Anxiety Disorder
Diagnosis from Clinicians
No Anxiety
Anxiety
Total
No anxiety
36
14
50
Anxiety
16
16
32
Total
52
30
82

33

ADCI

Table 11.
Frequency for Diagnosis of Panic Disorder
Diagnosis from Clinicians
No Panic
Panic Disorder
Total
No Panic
62
2
64
Panic Disorder
15
3
18
Total
77
5
82
Discussion
This study demonstrated the feasibility of an abbreviated diagnostic interview to detect
mental health disorders in integrated primary care clinics. The interview was developed to
address a lack of brief diagnostic tools (Gask et al., 2008; Possemato et al., 2018) with the goal
of reducing underdetection of mental health disorders that disproportionately impact racial
minorities, underinsured and underserved patients at integrated primary care clinics (Borowsky
et al., 2000; Williams et al., 2010). The development process for the interview was rigorous
using the Delphi method and expert reviews with the goal of improving the validity of the
measure and its acceptability and feasibility for the PCBH setting and brief treatment model.
This process yielded a brief, easy to use, electronic version of the Abbreviated Diagnostic
Clinical Interview (ADCI). Next, the ADCI was piloted at two clinics, ACC and Hayes, and
results were compared to provisional diagnoses provided by the participants’ mental health
providers. Overall, the ADCI and clinician diagnoses overlapped for anxiety disorders, especially
panic disorder. The ADCI and clinicians also had adequate agreement for identifying patients
who did not meet criteria for any mental health disorder. The ADCI identified significantly more
comorbid disorders, psychotic disorders and somatization disorders. The latter is also likely a
reflection of data collection occurring during the COVID-19 pandemic. Differences in diagnosis
between the ADCI and clinicians may come from the ADCI capturing more true cases or false
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positives; the design of this study was not able to evaluate this point and future work should
include additional mechanisms to validate ADCI diagnoses.
In the first study, the ADCI was developed and underwent an iterative review process
that ended after reaching adequate group agreement (Tables 2, 3, and 4; Figures 1 and 2). The
review process underwent three iterations using the Delphi Method with 14 expert reviewers.
The first was appropriately focused on item development, diagnostic inclusion, and initial
structure. A key change was the removal of the brief cognitive assessment due to the plethora of
validated measures that can be used in primary care (Ismail et al., 2010). The second focused on
incorporating initial feedback, organizing modules, and developing the diagnostic algorithm. The
third iteration aimed to transfer the ADCI into Qualtrics to code the diagnostic algorithm and
further revise the measure to achieve 80% agreement among the group of expert reviewers. The
Delphi method was crucial to the development of the ADCI both to provide structure for
recruiting expert reviews and to guide the feedback and revision process. Additionally, this
methodology increased the acceptability, validity and feasibility of the ADCI. The Delphi
method is focused on the principle that the group’s judgement or decisions are more valid than
an individual’s (Aichholzer, 2009; Kraj, 2015). The anonymity of the reviewers supports this
principle; therefore, expert review was conducted remotely via email and Qualtrics surveys to
remove the usual complexities of group dynamics that can occur during psychometric
development (e.g., halo effect, groupthink) while promoting the positive benefits of groups (e.g.,
diversity of thought and opinions; Aichholzer, 2009; Kraj, 2015). Reviewers were from a wide
range of expertise and levels of experience: researchers in psychopathology that have requisite
knowledge about diagnostic criteria and development of diagnostic measures; clinical
psychologists who supervise PCBH services with first-hand knowledge about how a measure
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might fit into the primary care model; and psychology doctorial trainees who are providing
mental health services to primary care patients. The diversity of expertise within the group of
reviewers lent itself to a range of rich feedback including structural, diagnostic, and clinical
aspects that strengthened the acceptability of the measure for PCBH and improved the feasibility.
Overall, the Delphi method proved to be a beneficial methodological tool that should be used
more often in psychometric development. In addition to the Delphi method and expert reviewers,
the diagnostic criteria used were obtained from the ICD-10 PHC and the DSM-5 guidelines. The
combination of these two classification systems helped to focus on brevity for the PCBH setting
while also using more updated classifications from the DSM-5, because the ICD-10 PHC was
released in 1994.
In the second study, the ADCI was successfully piloted in two integrated primary care
clinics and a total of 82 patients completed the interview via telephone (Tables 5 and 6). The
ADCI identified that 63.4% of participants met criteria for a mental health diagnosis which was
comparable to primary care clinicians identifying 64.7% of patients who met criteria for a
disorder. Both the ADCI and clinicians reported higher prevalence than the PCBH literature
which ranges from 30-52% of patients meeting criteria for a mental health concern (Ansseau et
al., 2004; Piontek et al., 2018; Spitzer et al., 1994). There are two factors that influence
interpreting this difference. First, these data were collected during the COVID pandemic and
rates of mental health concerns have been shown to be higher than previous times (Vindegaard &
Benros, 2020). Second, in the literature, there is significant methodological variability in
diagnosis of mental health disorder and quantifying its prevalence that interferes with comparing
the ADCI result to existing findings (e.g., Moreno-Küstner et al., 2018). The term “prevalence”
is used liberally to describe studies that include patients who are referred to mental health
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services or screened positive for mental health symptoms by their primary care providers (e.g.,
Ansseau et al., 2004), or will use symptom screeners (e.g., PHQ-9, GAD-7) as diagnostic tools
(e.g., Piontek et al., 2018; Shangguan et al., 2020); these methodologies can artificially inflate
prevalence rates while also missing patients who are not being screening or formally assessed.
Next, the ADCI also diagnosed significantly more comorbid disorders (approximately 40% of
patients) than one disorder (approximately 20%); the opposite was true for clinicians’ diagnoses.
Rates of comorbidity vary in the literature, from 21.2% across mood, anxiety and somatic
symptom disorders and mid-30% for alcohol use disorder with mood or anxiety disorder
(Ansseau et al., 2004), up to the mid-40s% for depression and anxiety comorbid with
somatization (Kroenke et al., 2007; Piontek et al., 2018).
Although the ADCI reported higher prevalence rates of disorder and comorbidity, rates of
depression and anxiety were lower than clinicians’ diagnoses. The ADCI identified 26.7% of
patients meeting criteria for depression. In a comparable study that used a clinical diagnostic
measure in primary care, 31% of patients were diagnosed with a mood disorder (Ansseau et al.,
2004). The ADCI diagnosed 22.5% of patients with generalized anxiety and 15% with panic
disorders. In the literature, diagnosis of anxiety disorders varies more than depression or mood
disorders. Studies have found that 15-19% of patients met criteria for an anxiety disorder, 7.610.8% for generalized anxiety and 2.8-6.8% for panic disorders (Ansseau et al., 2004; Kroenke
et al., 2007). Rate of somatization diagnosed by the ADCI (25.8%) was comparable to the
estimated point prevalence in a similar primary care study (Haller et al., 2015). The ADCI
diagnosed significantly fewer substance use disorders compared to primary care, where an
estimated 35% of patients meet criteria for at least one substance use disorder (John et al., 2018).
The ADCI diagnosed 5% of individuals with an episode of psychosis. A systematic review on
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the prevalence of psychosis revealed a significantly lower prevalence of 7.69 per 1000 people
over their lifetime (Moreno-Küstner et al., 2018). Overall, rates of diagnosis on the ADCI were
comparable to rates in the primary care literature with the exceptions of anxiety and psychosis
being higher while substance use was lower. These differences could be attributed to the impact
of the COVID pandemic heightening individuals’ concern regarding physical complaints and
that ACC and Hayes clinics routinely referring patients with substance use disorders to a
specialty primary care clinic (MOTIVATE clinic).
In the latter part of study 2, diagnoses from the ADCI were compared to those provided
by clinicians (Table 7). The ADCI and clinicians demonstrated significant overlap on detection
of any anxiety disorder, panic disorder, and differentiating between no disorder, depression,
anxiety, or both. In a similar study, rates of agreement and kappa sizes were similar (Piontek et
al., 2018). There were a few diagnoses on which the ADCI and clinicians did not agree:
depression, somatization, substance use and psychosis. Piontek and colleagues’ (2018) study
demonstrated agreement between PCPs and the Composite International Diagnostic Interview
(CIDI) for both depression and somatization. However, one key difference in their study
involved prescreening patients for symptoms before recruitment. Their methodological approach
likely improved their diagnostic agreement between the CIDI and PCPs. Lower levels of
agreement between ADCI and clinicians could also be a reflection of successful interventions
and patient improvement due to delay in collecting clinicians’ diagnoses after behavioral health
appointments. Another factor to consider when interpreting disagreement between the ADCI and
clinicians is the model of PCBH. Primary care clinics vary widely in how they integrate
psychologists and behavioral health services (Brown et al., 2021). Due to the COVID pandemic,
ACC and Hayes transitioned their behavioral health services to telemedicine (Perrin et al., 2020).
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Prior to COVID, clinicians often received referrals from PCPs via warm hand-offs, but since
COVID referrals have been made electronically which could have reduced the amount of
information exchanged across professions. Another reason for disagreement is that the PCBH
model focuses on brief intervention (<30 minutes) and patients often attend only one to three
appointments. Due to brevity, sessions are often focused on addressing the referral question
rather than on broader assessment which can lead to underdetection. For example, a patient
might be referred to behavior health for smoking cessation which would be the focus of one or
two sessions. The clinician and patient would work on strategies for reducing smoking and might
not have time to assess and treat additional mental health symptoms, leading to underdetection of
comorbid mental health symptoms. The ADCI might be a helpful tool for assessing whether
patients have other concerns or disorders present and reduce burden on clinicians to assess and
diagnose patients within a brief model of care. Additional diagnostic information can create a
fuller appreciation for and conceptualization of patients’ presenting concerns. The ADCI could
also help determine patients’ needs for community referrals due to comorbidity or increased
severity of mental health symptoms that would benefit from more than a few behavioral health
appointments. Nonetheless, it remains to be determined if the ADCI is overdetecting rates of
diagnosis, which is another possible explanation of the discrepancy.
The reasons for disagreement on somatic disorders may come from two additional
sources: perception of somatic symptoms among mental health professionals and the impact of
the COVID pandemic. The diagnosis of somatic disorders has long elicited strong opinions from
mental health providers and medical doctors. The revision of somatic disorders for DSM-5
attempted to reduce the number of disorders to avoid problematic overlap and make the criteria
more useful to medical providers (Lehmann et al., 2019; Scamvougeras & Howard, 2020).
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Somatic Symptom Disorder (SSD) became the new core disorder that is characterized by
persistent and clinically significant somatic complaints accompanied by excessive health-related
thoughts, feelings, and behaviors regarding symptoms (American Psychiatric Association, 2013).
Since the DSM-5 revisions, psychologists and medical providers have expressed difficulty with
the ambiguity and potential oversensitivity of the term “excessive” for psychological distress and
concerns about medical symptoms (Lehmann et al., 2019; Scamvougeras & Howard, 2020).
These concerns might account for the disagreement between the ADCI and clinicians. Also,
viewing the characteristics of SSD in the context of the COVID pandemic, it is apparent how
more patients might meet criteria due to widespread concerns about contracting the virus,
changes in individual behavior, public safety guidelines to prevent it , and increased selfmonitoring for symptoms. Additionally, patients who attend PCBH likely have health conditions
that could increase their risk for complications if they contracted COVID. However, the ADCI’s
detection rate of SSD was comparable to prevalence rates in primary care before the pandemic.
Assessing for SSD should be more routine in PCBH due to ease of screening, availability of brief
interventions that improve quality of life and reduce health care costs, and anticipated increase in
patients with somatic concerns following the COVID pandemic. There are several screening
measures for SSD, such as the Patient Health Questionnaire-15 (PHQ-15) or Somatic Symptom
Scale-8 (SSS-8), and somatic concerns have been shown to respond well to brief cognitivebehavioral interventions (Barsky & Ahern, 2004; Bourgault-Fagnou & Hadjistavropoulos, 2013;
Toussaint et al., 2019).
The COVID pandemic has significantly impacted the way primary care clinics operate as
they are transitioning behavioral health intervention to telemedicine (Perrin et al., 2020;
Sadicario et al., 2021). Recent findings suggest that due to the pandemic, significantly fewer
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patients are receiving diagnoses of anxiety, depression, circulatory system diseases, and type 2
diabetes, and fewer first time prescriptions were prescribed due to reduced patient load at
primary care clinics (Williams et al., 2020). A systematic review of the impact of COVID on
mental health demonstrated a pattern of patients with preexisting mental health disorders
experiencing an exacerbation of symptoms (Vindegaard & Benros, 2020). In the general
population, patients reported lower psychological well-being and higher levels of anxiety,
depression, illness anxiety, and somatization (Kecojevic et al., 2020; Vindegaard & Benros,
2020). Based on the COVID and mental health literature, it is more than likely that the ADCI
diagnostic rate is accurate with elevated somatization comorbid with depression or anxiety (Ran
et al., 2020; Shangguan et al., 2020).
Limitations
An unavoidable limitation of the study is that data collection occurred during the COVID
pandemic; however, the study provided a rare opportunity to assess how patients receiving
PCBH services were coping during the pandemic. The COVID pandemic not only impacted
participants’ mental health, but also limited recruitment. As a result, the study had difficulty
reaching an adequately powered sample size. Safety protocols due to COVID, including
remotely conducting the study, likely negatively impacted participant recruitment due to a
reduced number of patients being seen at primary care and to patients having difficulty utilizing
telemedicine. Remote interviews also limited the direct supervision of interview administration
and scoring.
The sample was also limited due to the data collection method and the remote nature of
the study. Only patients with email addresses and cellphones, and those who could afford cellular
data, were able to participate in the study; there were a few patients without email addresses who
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could not receive the gift card compensation. Additionally, conducting the interview via
telephone reduced the ecological validity of the ADCI. This has implications for how the ADCI
will be used in person. For example, administering and scoring the ADCI might be easier due to
additional response data and interviewer observations when conducting the interview in person.
Rapport and body language can be helpful sources of information during an interview and for
scoring that are not accessible during telephone interviews. Last, data collection was completed
by primarily undergraduate psychology students. Only one interviewer had experience working
in primary care clinics. PCBH providers were only part of the development process and have yet
to have the opportunity to use the measure in the clinics.
Clinical Implications
The primary outcome of the study was the creation of the ADCI, a brief clinical
diagnostic tool that mental health providers would be able to implement in PCBH clinics. The
ADCI fills a gap in PCBH tools to improve diagnosis of patients’ mental health concerns that
could contribute to rates of underdiagnosed minority patients. Disparities in health for racial
minority, low socioeconomic status (SES), or underserved populations are well documented and
contribute to disproportionate rates of these individuals experiencing mental health conditions.
Better detection of mental health symptoms has the potential to reduce the burden of these
symptoms on minority patients. The ADCI can also help clinical settings gain a better
understanding of their patients’ needs and improve mental health services by providing
information about the mental health disorders present in these communities.
Expert reviewers and the pilot trial using the ADCI both demonstrated that this measure
is feasible and acceptable to diagnose mental health concerns in PCBH. Also, the above findings
from the ADCI revealed ways to improve screening and intervention at our primary care clinics.
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The ADCI was designed for ease of use and does not require a psychologist to administer. Any
well-meaning, empathetic medical provider with an interest in mental health (e.g., nurse, medical
assistant, primary care provider) could learn to administer the ADCI. However, the ADCI does
require the interviewer to make decisions and use clinical judgement to score patients’ symptoms
as either present or absent. Our undergraduate-level psychology research assistants demonstrated
good interrater reliability after one three-hour training session and two practice interviews
completed with a peer. For providers with more clinical experience, less training would likely be
sufficient, such as a one-hour abbreviated training session and one or two peer supervised
administrations.
Future Directions
Future research on the ADCI should focus on clinical implications and continued
evaluation of its diagnostic accuracy and validity. At present, the ADCI’s validity is associated
with the validity of the screening tools and diagnostic criteria that were used to develop it.
However, formal validity studies could help determine whether the questions and the diagnostic
algorithm should be revised. Although the ADCI has implications for addressing racial health
disparities, future research should assess its ability to accurately diagnose and detect differential
rates of disorders among racial minorities.
Future research could also focus on the training and administration of the ADCI in
PCBH. The current study was limited in scope and impacted by the COVID pandemic; thus, we
were unable to implement the ADCI in the physical PCBH settings. For example, formally
assessing the necessary amount of for interviewers to learn to administration and score
accurately, whether booster trainings are needed, and the development of a credential or
certification program would be beneficial for implementation. Additionally, it would be useful to
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explore the relationship between implementing the ADCI at a clinic and tracking patients’
outcomes. Ideally, improvements in detection of mental health concerns would translate into
reductions of disorders and symptoms.
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Appendix A
Telephone Interview Script
Hello [Mr./Ms. patient’s name], my name is [RA’s name] and I’m calling from VCU
to follow up on the behavioral health appointment you attended at [ACC/ Hayes]. We are
conducting a research study and were hoping to talk with you to better understand your
behavioral and emotional health symptoms. This is a one-time phone interview that will
take about 60 minutes and participation is completely voluntary. Since the interview would
be for research purposes only, there is monetary compensation available your time and
effort in this study. Do you have time now to talk and hear more about the interview?
If patient needs more information:
• Reidentify the clinic they received care at and its affiliation with VCU and that follow-up
phone interviews about services are standard of care
• If they ask about your credentials: “I am a psychology research assistant supervised by
Dr. Keeley. If you have questions or concerns you can talk to him or our research
coordinator Julia Brechbiel at [research lab number]”
• If they would like to discuss details related to their appointment or clinical care at VCU
Health Services, please advise them to contact their provider. For example: “It sounds
like you have questions about your care or would like to talk to your provider, I
recommend that you contact the clinic or the provider directly."
In case we get disconnected, what's the best number to reach out at: [collect phone
number]
Do you have time now to talk and hear more about the interview?
• Yes
• Schedule follow-up phone call
• No – Declined to participate
[Review consent form]
Would you like me to email you a copy of the information I reviewed so you have our
contact information?
[If yes, collect email address]
Verbal Consent
Do you consent to participate?
• Yes
• No
IF YES:
Just as a reminder, you attended a behavioral health psychology session in the past two
weeks. For this research study, what I’d like to do today is check in and see how you’re
doing by asking you questions about your thoughts and emotions. Everything you tell me
today will be confidential and won’t be shared with anyone without your permission. If you
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would prefer to skip or not answer a question, please let me know and you are welcome to
discontinue the interview at any time.
[Administer Diagnostic Clinical Interview]
If patient endorses suicidal ideation:
OK, so from what you’ve told me it looks like you are having thoughts [insert patient's
language here]. I want to make sure that you are safe and receiving support to cope with
these thoughts. I am going to place you on a brief hold to consult with a colleague to make
sure you receive the best support.
• Place patient on hold/mute and discuss the case with Dr. Keeley and agree to a plan to
provide patient with information for clinical services or directions to emergency care
depending on the severity of thoughts, intent, and plan.
• If you are disconnected from a patient in active crisis and they are no longer
reachable: Please notify Dr. Keeley who will follow clinical procedure by looking up
their address in their medical record and contacting Richmond police who will conduct a
wellness check
Thank you for holding, let me provide you with some helpful resources.
Here are 24/7 numbers for national suicide hotlines: 1-800-784-2433 or 1-800-273-8255. Or
if you need someone to talk but you are not having suicidal thoughts you can call the
Virginia warm line: 1-866-400-6428. The warm line is available Mon-Fri 9am-9p, and 5pm9pm Sat-Sun.
If you are unsafe, it is always best to call 911 or go to the ER immediately.
You've completed the interview, thank you for your time! Let me make sure I have your
email address to send you the $10 gift card.
[record email address below]
If you are interested in counseling, I can provide you with some local resources. Would you
like the number of the clinic you recently visited (ACC: 804-828-9000 / Hayes: 804-2307777), or a referral number for somewhere else in the community (see below referral
numbers)?
Remember services at [ACC/Hayes] are always available to you as long as you’re a patient
at [ACC/Hayes]. Again, thank you so much for your time, [patient name].
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Counseling Services – Referral Information
Community Services Boards
Richmond Behavioral Health Authority (City of Richmond)
Counseling and psychiatry services: (804) 819-4000
Emergency services: (804) 819-4100
http://bewellva.com/richmond/
Hanover County
All Services (Emergency included): (804) 365-4200
https://www.hanovercounty.gov/358/Community-Services-Board
Henrico County
Counseling and psychiatry services: (804) 727-8500
Emergency services: (804) 727-8484
http://www.co.henrico.va.us/mhmr
District 19 (Petersburg and Tri-Cities)
Counseling and psychiatry services: (804) 862-8002
Emergency services: (804) 862-8000
http://www.d19csb.com
Chesterfield County
Counseling and psychiatry services: (804) 768-7318
Emergency services: (804) 748-6356
https://www.chesterfield.gov/878/Mental-Health-Support-Services
Therapy Clinics (Accept Medicaid or affordable sliding fee scale)
Center for Psychological Services and Development
612 North Lombardy Street, Richmond, VA 23284
(804) 828-8069 • http://www.has.vcu.edu/psy/cpsd/
Jewish Family Services: Accepts families of all faiths
6718 Patterson Ave, Richmond, VA 23226
(804) 282-5644 x 234 • http://www.jfsrichmond.org
Dominion Behavioral Healthcare
Midlothian: Courthouse Rd (804) 794-4482; Harbor Pointe (804) 639-1136
West End: Pembrooke Medical Center (804) 270-1124
If it is an emergency: CALL 911
Suicide Hotlines: 1-800-784-2433 or 1-800-273-8255
VA Warmline: 1-866-400-6428
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Appendix B
Table 12.
Frequency of Patients Meeting Criteria for a Diagnosis
Diagnosis from Clinicians
No Diagnosis
Meets Criteria
Total
No Diagnosis
9
20
29
Meets Criteria
18
35
53
Total
27
55
82

Total
50
32
82

Table 14.
Frequency for Diagnosis of Generalized Anxiety Disorder (GAD)
Diagnosis from Clinicians
No GAD
GAD
No GAD
38
17
GAD
16
11
Total
54
28

Total
55
27
82

ADCI

ADCI

Table 13.
Frequency for Diagnosis of Depression
Diagnosis from Clinicians
No Depression Depression
No Depression
34
16
Depression
18
14
Total
52
30

ADCI

Table 15.
Frequency for Diagnosis of a Substance Use Disorder (SUD)
Diagnosis from Clinicians
No SUD
SUD
Total
No SUD
75
6
81
SUD
1
0
1
Total
76
6
82

ADCI

Table 16.
Frequency for Diagnosis of Somatic Symptom Disorder (SSD)
Diagnosis from Clinicians
No SSD
SSD
No SSD
51
0
SSD
29
2
Total
80
2

Total
51
31
82
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Table 17.
Frequency for Diagnosis of Psychosis

No psychosis
Psychosis
Total

Diagnosis from Clinicians
No Psychosis
Psychosis
Total
76
0
76
6
0
6
82
0
82

ADCI

Table 18.
Frequency of Comorbid Disorders

None
One disorder
More than one
Total

None
10
9
10
2

Diagnosis from Clinicians
One disorder More than one
17
3
8
0
14
11
39
14

Total
30
17
35
82

